GenMark Diagnostics ROA 2010-2018 | GNMK

Current and historical return on assets (ROA) values for GenMark Diagnostics (GNMK) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. GenMark Diagnostics ROA for the three months ending September 30, 2018 was -50.74%.
GenMark Diagnostics ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $-0.05B $0.09B -51.18%
2018-06-30 $-0.06B $0.10B -50.43%
2018-03-31 $-0.06B $0.11B -46.46%
2017-12-31 $-0.06B $0.12B -53.80%
2017-09-30 $-0.06B $0.13B -57.28%
2017-06-30 $-0.06B $0.15B -60.64%
2017-03-31 $-0.05B $0.06B -70.99%
2016-12-31 $-0.05B $0.08B -70.34%
2016-09-30 $-0.05B $0.09B -66.90%
2016-06-30 $-0.05B $0.06B -67.65%
2016-03-31 $-0.05B $0.06B -61.43%
2015-12-31 $-0.04B $0.07B -51.85%
2015-09-30 $-0.04B $0.08B -48.70%
2015-06-30 $-0.04B $0.08B -44.81%
2015-03-31 $-0.04B $0.09B -41.13%
2014-12-31 $-0.04B $0.09B -37.96%
2014-09-30 $-0.04B $0.10B -37.19%
2014-06-30 $-0.04B $0.11B -35.59%
2014-03-31 $-0.04B $0.11B -36.97%
2013-12-31 $-0.03B $0.12B -36.56%
2013-09-30 $-0.03B $0.13B -35.22%
2013-06-30 $-0.02B $0.06B -35.66%
2013-03-31 $-0.02B $0.06B -30.55%
2012-12-31 $-0.02B $0.07B -37.86%
2012-09-30 $-0.02B $0.07B -43.19%
2012-06-30 $-0.02B $0.07B -48.94%
2012-03-31 $-0.02B $0.03B -55.76%
2011-12-31 $-0.02B $0.04B -61.94%
2011-09-30 $-0.02B $0.04B -64.79%
2011-06-30 $-0.02B $0.05B -69.84%
2011-03-31 $-0.02B $0.02B -77.78%
2010-12-31 $-0.02B $0.03B -88.37%
2010-09-30 $-0.02B $0.03B -137.70%
2010-06-30 $-0.02B $0.03B -266.67%
2010-03-31 $-0.02B $0.00B inf%
2009-12-31 $-0.02B $0.00B inf%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.254B $0.053B
GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. The eSensor? XT-8 system is the second generation in GenMark Dx's eSensor? platform, utilizing electrochemical detection technology to detect nucleic acids on a microarray. The XT-8 System enables multiplex detection of DNA and RNA targets. The Company has developed four diagnostic tests for use with its XT-8 System. Its Cystic Fibrosis Genotyping Test, which detects pre-conception risks of cystic fibrosis, and its Warfarin Sensitivity Test, which determines an individual's ability to metabolize the oral anticoagulant warfarin, have received FDA clearance. It has also developed a Respiratory Viral Panel Test, which detects the presence of major respiratory viruses, and a Thrombosis Risk Test, which detects an individual's increased risk of blood clots. GenMark Diagnostics, Inc. is based in Pasadena, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $94.638B 22.05
Intuitive Surgical (ISRG) United States $56.945B 56.03
Edwards Lifesciences (EW) United States $31.075B 33.26
Fresenius Medical Care AG KGaA (FMS) Germany $24.473B 16.57
IDEXX Laboratories (IDXX) United States $16.961B 48.45
ABIOMED (ABMD) United States $14.078B 101.15
DexCom (DXCM) United States $12.334B 0.00
Teleflex (TFX) United States $11.768B 26.71
Hologic (HOLX) United States $10.836B 17.78
Varian Medical Systems (VAR) United States $10.500B 26.01
STERIS (STE) United Kingdom $9.837B 26.10
Masimo (MASI) United States $5.746B 37.26
LivaNova (LIVN) United Kingdom $5.698B 36.58
Globus Medical (GMED) United States $4.956B 31.14
Penumbra (PEN) United States $4.483B 270.69
Integra LifeSciences Holdings (IART) United States $4.474B 21.79
Wright Medical Group (WMGI) Netherlands $3.542B 0.00
Cantel Medical (CMD) United States $3.428B 34.54
Inogen (INGN) United States $2.825B 60.97
Integer Holdings (ITGR) United States $2.671B 22.35
Halyard Health (AVNS) United States $2.230B 20.09
Glaukos (GKOS) United States $1.993B 0.00
OPKO Health (OPK) United States $1.808B 0.00
Tandem Diabetes Care (TNDM) United States $1.799B 0.00
Mazor Robotics (MZOR) Israel $1.532B 0.00
AxoGen (AXGN) United States $1.233B 0.00
Nevro (NVRO) United States $1.183B 0.00
Luminex (LMNX) United States $1.156B 41.84
Pacific Biosciences Of California (PACB) United States $1.135B 0.00
Orthofix (OFIX) United States $1.086B 31.37
Tactile Systems Technology (TCMD) United States $1.068B 169.97
CryoLife (CRY) United States $1.050B 92.07
Natus Medical (BABY) United States $1.021B 21.44
Intersect ENT (XENT) United States $0.939B 0.00
Accelerate Diagnostics (AXDX) United States $0.770B 0.00
AngioDynamics (ANGO) United States $0.765B 26.75
Mesa Laboratories (MLAB) United States $0.761B 45.02
TransEnterix (TRXC) United States $0.648B 0.00
Veracyte (VCYT) United States $0.540B 0.00
Sientra (SIEN) United States $0.530B 0.00
ViewRay (VRAY) United States $0.485B 0.00
SI-BONE INC (SIBN) United States $0.410B 0.00
Accuray (ARAY) United States $0.398B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.394B 0.00
OrthoPediatrics (KIDS) United States $0.338B 0.00
Neuronetics (STIM) United States $0.327B 0.00
Quotient (QTNT) Switzerland $0.321B 0.00
Nuvectra (NVTR) United States $0.313B 0.00
Fluidigm (FLDM) United States $0.297B 0.00
SeaSpine Holdings (SPNE) United States $0.294B 0.00
IRadimed (IRMD) United States $0.282B 73.66
RTI Surgical (RTIX) United States $0.279B 44.00
CRH Medical (CRHM) Canada $0.238B 41.00
Corindus Vascular Robotics (CVRS) United States $0.226B 0.00
Helius Medical Technologies (HSDT) United States $0.216B 0.00
Pulse Biosciences (PLSE) United States $0.209B 0.00
T2 Biosystems (TTOO) United States $0.193B 0.00
Ekso Bionics Holdings (EKSO) United States $0.132B 0.00
Alphatec Holdings (ATEC) United States $0.127B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.103B 0.00
Ra Medical Systems (RMED) United States $0.103B 0.00
Second Sight Medical Products (EYES) United States $0.100B 0.00
Sensus Healthcare (SRTS) United States $0.094B 0.00
Restoration Robotics (HAIR) United States $0.077B 0.00
Biosig Technologies (BSGM) United States $0.071B 0.00
Apollo Endosurgery (APEN) United States $0.071B 0.00
EDAP TMS (EDAP) France $0.068B 0.00
Viveve Medical (VIVE) United States $0.066B 0.00
Electromed (ELMD) United States $0.050B 24.04
OBALON THERPTCS (OBLN) United States $0.047B 0.00
Xtant Medical Holdings (XTNT) United States $0.042B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.037B 0.00
Vermillion (VRML) United States $0.036B 0.00
Neovasc (NVCN) Canada $0.035B 0.00
ConforMIS (CFMS) United States $0.033B 0.00
PAVmed (PAVM) United States $0.028B 0.00
Lianluo Smart (LLIT) China $0.028B 0.00
Titan Medical (TMDI) Canada $0.027B 0.00
Dynatronics (DYNT) United States $0.024B 0.00
DarioHealth (DRIO) Israel $0.022B 0.00
ENDRA Life Sciences (NDRA) United States $0.021B 0.00
ReWalk Robotics (RWLK) Israel $0.020B 0.00
Nanovibronix (NAOV) United States $0.016B 0.00
Presbia (LENS) Ireland $0.016B 0.00
American Shared Hospital Services (AMS) United States $0.015B 11.65
Bioanalytical Systems (BASI) United States $0.014B 0.00
Microbot Medical (MBOT) United States $0.010B 0.00
Micron Solutions (MICR) United States $0.010B 0.00
Allied Healthcare Products (AHPI) United States $0.008B 0.00
Sunshine Heart Inc (CHFS) United States $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
Atossa Genetics (ATOS) United States $0.006B 0.00
InspireMD (NSPR) Israel $0.005B 0.00
Avinger (AVGR) United States $0.004B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00
EnteroMedics (RSLS) United States $0.000B 0.00
Amedica (SINT) United States $0.000B 0.00